American College of Rheumatology

http://www.rheumatology.org/

Last activity: 24.10.2025

Active

Categories: CareCollegeEdTechHealthTechInformationManagementMedTechNonprofitResearchSpecialty

The American College of Rheumatology's mission is to empower rheumatology professionals to excel in their speciality. Our membership includes physicians, health professionals, and scientists who embody our mission through their commitment to education, research, advocacy, and practice support. Our organization is dedicated to protecting patient access to quality care and to providing credible, evidence-based information and resources on the subject of rheumatic disease.

We provide professional education for our members through several venues. The Annual Scientific Meeting is the premier scientific meeting devoted to the study, treatment and impact of rheumatic disease in the United States and abroad. This meeting draws thousands of rheumatologists and specialized health professionals from around the world. A number of other topical conferences, meetings, and online courses round out the ACR's educational offerings.

The ACR publishes Arthritis & Rheumatology, the premier scientific journal for research in the rheumatic diseases. Arthritis Care & Research is published by the Association of Rheumatology Health Professionals, a division of the ACR. This journal focuses on the health services and clinical aspects of rheumatology.

Twitter Facebook LinkedIn Youtube Email App Store

Likes

23.97K

Website visits

308.4K /mo.

Mentions

Overview

Location

South Africa, North West, Atlanta

Employees

51-200

Phone

+1 404-633-3777

Founded date

1934

Mentions in press and media 24

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Oct 14, 2025	2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China	In the results of China Phase III clinical trial announced at the 2025 ACR, Telitacicept demonstrated statistically significant and clinically meaningful improvements in ESSDAI [EULAR (European League Against Rheumatism) Sjögren's Synd...
Sep 17, 2025	Saphnelo met primary endpoint in TULIP-SC	Saphnelo met primary endpoint in TULIP-SC Wed, Sep 17, 2025 08:05 CET Report this content 17 September 2025 Saphnelo self-administration TULIP-SC Phase III trial meets primary endpoint in patients with systemic lupus erythematosus based on ...
May 22, 2024	Carbon Biosciences Announces New Appointments to Board of Directors and Scientific Advisory Board	- Carol Ann Satler, MD, PhD, FACC, FAHA, FAAP joins the Board of Directors, adding key clinical experience to guide ongoing nonclinical development in cardiac and pulmonary diseases - - Lloyd Klickstein, MD, PhD joins the Scientific Advisor...
May 10, 2024	RemeGen Celebrates World Lupus Day 2024 with Increased Lupus Visibility through Vital Knowledge Sharing	The biotech company continues to offer hope to systemic lupus erythematosus (SLE) patients globally by sharing the latest developments of its proprietary novel fusion protein drug Telitacicept YANTAI, China, May 10, 2024 /PRNewswire/ -- Rem...
Jan 18, 2024	Health \| Fear of opioids causing relapse has those in addiction recovery needing joint replacement cautious	The pain in Gary Emes’ hip was excruciating, but the fear of relapsing into addiction was stronger. He suffered for five years before he finally decided to pursue joint replacement surgery. “The hip at that time was about 60-70% deteriorate...
Nov 15, 2023	RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology	YANTAI, China, Nov. 15, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a commercial-stage biotechnology company, is invited to present telitacicept Phase III Clinical Trial ...
Nov 23, 2022	ACR: Genicular Nerve Block Offers Short-Term Pain Relief for Knee OA	WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- Genicular nerve block offers pain relief for patients with knee osteoarthritis, according to a study published online Nov. 11 in Arthritis & Rheumatology to coincide with the annual meeting o...
Nov 21, 2022	ACR: Opioids Raise Risk for VTE in Patients With Rheumatoid Arthritis	MONDAY, Nov. 21, 2022 (HealthDay News) -- Opioid initiation among patients with rheumatoid arthritis (RA) is associated with similar major adverse cardiovascular events (MACE) and all-cause mortality risk versus nonsteroidal anti-inflammato...
Sep 16, 2022	Guidelines Issued for Vaccination in Patients With Rheumatic, Musculoskeletal Diseases	FRIDAY, Sept. 16, 2022 (HealthDay News) -- In new guidelines issued by the American College of Rheumatology, evidence-based recommendations are presented for the use of vaccinations in children and adults with rheumatic and musculoskeletal ...
May 20, 2022	Novartis Cosentyx® (secukinumab) receives positive CHMP opinion for expanded use in childhood arthritic conditions	Positive opinion could expand the role of Cosentyx®(secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU Safety in these pediatric populations was consistent wi...
Jan 27, 2022	Newer Rheumatoid Arthritis Drug Might Raise Heart, Cancer Risks	THURSDAY, Jan. 27, 2022 (HealthDay News) -- Finding the right medication for rheumatoid arthritis isn't easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clini...
Jan 11, 2022	NICE recommends AbbVie’s RINVOQ[® ▼ (upadacitinib) ]For Use in Adults with Active Psoriatic Arthritis	NICE recommends AbbVie’s RINVOQ[® ▼ (upadacitinib) ]For Use in Adults with Active Psoriatic Arthritis Tue, Jan 11, 2022 17:50 CET This decision means that upadacitinib will be available in England and Wales for eligible patients with previo...
Dec 22, 2021	Novartis Cosentyx® receives FDA approval for the treatment of children and adolescents with enthesitis-related arthritis and psoriatic arthritis	New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in disease activity observed over two years across both enthesitis-related arthritis (ERA) and pso...
Nov 20, 2021	8 reasons why your hands might be tingling and how to treat it	Reviews Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options. Health 8 reasons why your hands might be tingling and how to treat it Written by Kelly Burch; edited by Jessica Orwig 2021-11-...
Dec 15, 2020	How a young woman became empowered to improve her rheumatoid arthritis care	(BPT) - At a young age, Randi learned the importance of self-advocacy and honest conversations in the face of health struggles. Like most kids, she enjoyed sports and being active. When she was 10 years old, she started having pain in the ...
Dec 15, 2020	How a young woman became empowered to improve her rheumatoid arthritis care	(BPT) - At a young age, Randi learned the importance of self-advocacy and honest conversations in the face of health struggles. Like most kids, she enjoyed sports and being active. When she was 10 years old, she started having pain in the ...
Dec 8, 2020	Relapsing Polychondritis Patients and Advocates Emphasize the Benefits of Collaboration in Prestigious Patient Perspective Poster Program	We were honored to have so many RP patients represented and encouraged by the progress of the research, which was presented to 16,000 attendees. NEW YORK (PRWEB) December 08, 2020 The American College of Rheumatology (ACR) held its annual m...
Jan 11, 2019	Virtual repurposing can speed the discovery of new uses for existing drugs	The process for discovering drugs tends to be based on the same kind of pigeonholing that doctors use to treat disease: Parkinson’s is one disease, Crohn’s is something completely separate. A new approach, sometimes called virtual repurposi...
Jul 11, 2017	Updating drug labels would greatly help patients — but few companies do it	Do you ever look at the labels of the prescription medications you take? Or do you simply rely on your physician to read them to understand the medications’ appropriate uses and side effects? Either way, there’s a good chance that these lab...
Jan 25, 2017	Battle erupts over how to treat gout, no longer the ‘disease of kings’	It was once seen as the disease of kings, afflicting only the lazy and gluttonous. These days, however, gout is everywhere — and a bitter battle has broken out among physicians about how best to treat it. A form of arthritis, gout is charac...
Oct 28, 2013	Bristol-Myers, Alder Drug for Rheumatoid Arthritis Passes Key Test	Share Share on Facebook Share on Twitter LinkedIn Email Reprints Four years ago, the CEO of Bothell, WA-based Alder Biopharmaceuticals declared that his company’s experimental rheumatoid arthritis drug would someday give multibillion-dollar...
	A new study points to a surprisingly simple way to ward off knee pain	A promising new study suggests that walking could ward off knee pain for people with osteoarthritis. Researchers surveyed over 1,000 people ages 50 or older with knee osteoarthritis, the most common type of arthritis in the United States. S...
	Lady Gaga says this is what having fibromyalgia feels like: 'It’s every day waking up not knowing how you’re going to feel'	Five years ago, Lady Gaga revealed that she had fibromyalgia, a chronic illness so intense that it led to "severe pain" and tour cancellations during her music career. Fibromyalgia is a long-lasting disorder that "causes pain...

Reviews 0

FAQ about American College of Rheumatology

When was American College of Rheumatology founded?

American College of Rheumatology was founded in 1934.

What has the press written about American College of Rheumatology?

Parsers VC has collected 24 articles mentioning American College of Rheumatology, among them “2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China” (Oct 14, 2025) and “Saphnelo met primary endpoint in TULIP-SC” (Sep 17, 2025).

Is American College of Rheumatology still active?

Yes, American College of Rheumatology is active; its latest activity on Parsers VC dates from Oct 24, 2025.